OXYGENTA PHARMACEUTICAL
|
OXYGENTA PHARMACEUTICAL Last 5 Year Cashflow Statement History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Profit Before Tax | ₹-22 Cr | ₹-14 Cr | ₹-14 Cr | ₹-11 Cr | ₹-0.49 Cr |
| Adjustment | ₹8.03 Cr | ₹6.61 Cr | ₹4.31 Cr | ₹3.53 Cr | ₹2.51 Cr |
| Changes In working Capital | ₹-14 Cr | ₹11 Cr | ₹-3.49 Cr | ₹6.20 Cr | ₹-3.58 Cr |
| Cash Flow after changes in Working Capital | ₹-28 Cr | ₹2.83 Cr | ₹-13 Cr | ₹-1.63 Cr | ₹-1.56 Cr |
| Cash Flow from Operating Activities | ₹-28 Cr | ₹2.83 Cr | ₹-13 Cr | ₹-1.63 Cr | ₹-1.68 Cr |
| Cash Flow from Investing Activities | ₹-14 Cr | ₹-11 Cr | ₹-4.09 Cr | ₹-9.64 Cr | ₹-4.94 Cr |
| Cash Flow from Financing Activities | ₹43 Cr | ₹8.49 Cr | ₹17 Cr | ₹11 Cr | ₹6.33 Cr |
| Net Cash Inflow / Outflow | ₹0.42 Cr | - | ₹-0.01 Cr | ₹-0.05 Cr | ₹-0.29 Cr |
| Opening Cash & Cash Equivalents | ₹0.00 Cr | ₹0.00 Cr | ₹0.11 Cr | ₹0.16 Cr | ₹0.45 Cr |
| Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - | - | - |
| Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - | - | - |
| Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - | - |
| Effect of Foreign Exchange Fluctuations | - | - | - | - | - |
| Closing Cash & Cash Equivalent | ₹0.42 Cr | ₹0.00 Cr | ₹0.10 Cr | ₹0.11 Cr | ₹0.16 Cr |
Compare Cashflow Statement of peers of OXYGENTA PHARMACEUTICAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| OXYGENTA PHARMACEUTICAL | ₹203.5 Cr | -7.5% | 12.2% | -27% | Stock Analytics | |
| No other companies found in this Industry | ||||||
OXYGENTA PHARMACEUTICAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| OXYGENTA PHARMACEUTICAL | -7.5% |
12.2% |
-27% |
| SENSEX | -1% |
-2.9% |
-4.9% |
You may also like the below Video Courses